This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| ED | 1270 |
| der | 1177 |
| von | 580 |
| und | 434 |
| werden | 405 |
| bei | 390 |
| COVID-19 | 387 |
| mit | 342 |
| CI | 273 |
| eine | 271 |
| zu | 263 |
| CT | 258 |
| US | 239 |
| ¼ | 232 |
| zur | 226 |
| den | 220 |
| ist | 216 |
| Background | 216 |
| • | 212 |
| nicht | 209 |
| MD | 203 |
| sind | 202 |
| C | 199 |
| Fig | 195 |
| PoPCoin | 194 |
| oder | 191 |
| durch | 189 |
| Hospital | 177 |
| University | 175 |
| SARS | 175 |
| auf | 170 |
| wird | 169 |
| EMS | 165 |
| auch | 158 |
| B. | 158 |
| Italy | 151 |
| einer | 150 |
| March | 150 |
| Health | 149 |
| EM | 146 |
| sich | 142 |
| AE | 138 |
| nach | 137 |
| des | 134 |
| das | 130 |
| January | 127 |
| Patienten | 125 |
| II | 125 |
| LOS | 124 |
| China | 123 |
| A | 122 |
| z. | 122 |
| dass | 120 |
| CC | 119 |
| Bei | 119 |
| BMI | 115 |
| July | 112 |
| GERD | 112 |
| CoV-2 | 111 |
| als | 107 |
| June | 106 |
| ND | 105 |
| New | 103 |
| ein | 102 |
| BY | 101 |
| CPR | 98 |
| Table | 95 |
| ICU | 95 |
| United | 93 |
| Department | 93 |
| dem | 90 |
| kann | 89 |
| Y | 89 |
| nur | 88 |
| April | 87 |
| ICG | 87 |
| mg | 87 |
| T | 86 |
| vor | 84 |
| States | 84 |
| Medical | 84 |
| LSG | 83 |
| October | 81 |
| EDs | 81 |
| sie | 80 |
| RYGB | 80 |
| December | 80 |
| IV | 79 |
| USA | 78 |
| medRxiv | 77 |
| für | 77 |
| SD | 74 |
| Group | 74 |
| SSI | 73 |
| Laparoscopic | 73 |
| IQR | 73 |
| Coronavirus | 72 |
| aus | 71 |
| HIV | 70 |
| ACS | 69 |
| RNA | 69 |
| May | 69 |
| Surgery | 69 |
| _ | 69 |
| können | 69 |
| National | 68 |
| NC | 68 |
| India | 67 |
| III | 67 |
| Center | 67 |
| Impact | 66 |
| B | 66 |
| August | 66 |
| Disease | 65 |
| Germany | 64 |
| Anwendung | 64 |
| über | 64 |
| gegen | 63 |
| ERCP | 63 |
| Emergency | 62 |
| min | 61 |
| York | 61 |
| Wirksamkeit | 60 |
| Poisson | 60 |
| einem | 59 |
| bzw | 58 |
| TPU | 58 |
| Infektionen | 57 |
| February | 57 |
| World | 57 |
| quanta | 57 |
| keine | 56 |
| RBI | 56 |
| Desinfektion | 56 |
| sowie | 56 |
| CHX | 55 |
| S | 54 |
| GDP | 54 |
| Acuity | 54 |
| SG | 54 |
| U.S. | 54 |
| müssen | 54 |
| GATC | 53 |
| I | 53 |
| ± | 52 |
| MP | 52 |
| › | 51 |
| Figure | 51 |
| ≈ | 50 |
| September | 50 |
| Desinfektionsmittel | 50 |
| K | 49 |
| N | 49 |
| OP | 49 |
| bis | 49 |
| System | 49 |
| kg | 48 |
| Wirkung | 48 |
| Transmission | 48 |
| Post | 48 |
| Japan | 48 |
| Committee | 48 |
| Antibiotika | 48 |
| wie | 48 |
| Prophylaxe | 47 |
| J | 47 |
| State | 47 |
| range | 47 |
| Risk | 46 |
| Medicine | 46 |
| MRI | 46 |
| H1N1 | 46 |
| Government | 46 |
| A. | 46 |
| Kramer | 45 |
| ASA | 45 |
| American | 45 |
| Analysis | 45 |
| DOI | 45 |
| Fraction | 45 |
| Switzerland | 45 |
| NUHI | 45 |
| S. | 45 |
| aber | 45 |
| wenn | 45 |
| wurde | 45 |
| R | 45 |
| CBD | 44 |
| C. | 44 |
| Europe | 44 |
| Surgical | 44 |
| sha | 43 |
| dmnl | 43 |
| da | 43 |
| Verfahren | 43 |
| J. | 43 |
| Data | 43 |
| AED | 43 |
| CPUE | 42 |
| Case | 42 |
| MDD | 42 |
| Austria | 42 |
| HPeV | 42 |
| PCR | 42 |
| sein | 42 |
| ohne | 42 |
| p.001 | 42 |
| TH | 42 |
| Patient | 41 |
| M. | 41 |
| Organization | 41 |
| Anforderungen | 41 |
| SIR | 41 |
| jedoch | 41 |
| muss | 41 |
| k(t | 40 |
| einen | 40 |
| Wuhan | 40 |
| Sie | 40 |
| E. | 40 |
| Das | 40 |
| R0 | 39 |
| COPD | 39 |
| D | 39 |
| ETCO | 39 |
| Control | 39 |
| Report | 39 |
| es | 39 |
| nan | 39 |
| P. | 39 |
| eines | 39 |
| South | 39 |
| − | 38 |
| OHCA | 38 |
| FoodNet | 38 |
| Es | 38 |
| Erreger | 38 |
| Antibiotikaprophylaxe | 37 |
| GI | 37 |
| L | 37 |
| LC | 37 |
| Policy | 37 |
| LRYGB | 37 |
| Tab | 36 |
| TBI | 36 |
| Index | 36 |
| Einsatz | 36 |
| Appendix | 36 |
| General | 35 |
| Der | 35 |
| LA | 35 |
| Surg | 35 |
| Global | 34 |
| Association | 34 |
| ECG | 34 |
| FLS | 34 |
| vom | 34 |
| SILS | 34 |
| TAPP | 34 |
| T. | 34 |
| G | 33 |
| ANOVA | 33 |
| Asymptomatic | 33 |
| Bereich | 33 |
| COVID | 33 |
| Covid | 33 |
| Da | 33 |
| < | 33 |
| HIA | 33 |
| IM | 33 |
| November | 33 |
| Spain | 33 |
| Time | 33 |
| i | 33 |
| unter | 33 |
| Haut | 33 |
| Eingriffen | 32 |
| APAP | 32 |
| Aufbereitung | 32 |
| Australia | 32 |
| CDC | 32 |
| Care | 32 |
| Eine | 32 |
| LP | 32 |
| Gabe | 32 |
| Infectious | 32 |
| M | 32 |
| Risiko | 32 |
| VAS | 32 |
| mm | 32 |
| sollte | 32 |
| Endosc | 31 |
| G. | 31 |
| Für | 31 |
| IRB | 31 |
| DNA | 31 |
| CME | 31 |
| CAD | 31 |
| MI | 31 |
| IRT | 31 |
| Institute | 31 |
| Monetary | 31 |
| Score | 31 |
| Sterilisation | 31 |
| Studien | 31 |
| Study | 31 |
| Testing | 31 |
| dieser | 31 |
| noch | 31 |
| preprint | 31 |
| wegen | 31 |
| PE | 30 |
| Chi | 30 |
| ESD | 30 |
| Eq | 30 |
| NDC | 30 |
| P<0.001 | 30 |
| TME | 30 |
| Review | 30 |
| Society | 30 |
| Test | 30 |
| die | 30 |
| meta | 30 |
| zwischen | 30 |
| R. | 29 |
| EMR | 29 |
| Formaldehyd | 29 |
| GCS | 29 |
| Maßnahmen | 29 |
| Prevention | 29 |
| Reinigung | 29 |
| U | 29 |
| UK | 29 |
| p.05 | 29 |
| zum | 29 |
| School | 29 |
| Fisher | 28 |
| ICH | 28 |
| AUC | 28 |
| Bedeutung | 28 |
| CTA | 28 |
| EU | 28 |
| Likert | 28 |
| Influenza | 28 |
| NI | 28 |
| Nissen | 28 |
| Research | 28 |
| Use | 28 |
| allem | 28 |
| Empfehlungen | 27 |
| Model | 27 |
| Korea | 27 |
| RSI | 27 |
| CA | 27 |
| Assessment | 27 |
| ACGME | 27 |
| RA | 27 |
| pH | 27 |
| Rate | 27 |
| W. | 27 |
| Zur | 27 |
| diese | 27 |
| etwa | 27 |
| hernia | 27 |
| sera | 27 |
| SAH | 27 |
| Infection | 26 |
| AGB | 26 |
| Antiseptik | 26 |
| E | 26 |
| European | 26 |
| HH | 26 |
| Händedesinfektion | 26 |
| City | 26 |
| MIS | 26 |
| Prüfung | 26 |
| Public | 26 |
| WT | 26 |
| chi | 26 |
| gegenüber | 26 |
| wurden | 26 |
| Praxis | 26 |
| Dr | 25 |
| 8) | 25 |
| AF | 25 |
| Active | 25 |
| CLE | 25 |
| College | 25 |
| Deutschland | 25 |
| MMR | 25 |
| Hände | 25 |
| Infektion | 25 |
| MPC | 25 |
| OR | 25 |
| Washington | 25 |
| deCODE | 25 |
| verwendet | 25 |
| CO | 24 |
| EAPR | 24 |
| CRC | 24 |
| EN | 24 |
| Behandlung | 24 |
| Bank | 24 |
| Bakterien | 24 |
| EEG | 24 |
| F | 24 |
| þ | 24 |
| Introduction | 24 |
| L. | 24 |
| Mortem | 24 |
| PAP | 24 |
| SDD | 24 |
| TstSts | 24 |
| thoracoscopic | 24 |
| H3N2 | 24 |
| GFR | 23 |
| Mexico | 23 |
| Krankenhaus | 23 |
| Infected | 23 |
| H. | 23 |
| BLS | 23 |
| Ein | 23 |
| CRP | 23 |
| Als | 23 |
| Novel | 23 |
| Multiplier | 23 |
| Fatality | 23 |
| OCT | 23 |
| st | 23 |
| Population | 23 |
| sehr | 23 |
| gibt | 23 |
| denen | 23 |
| meist | 23 |
| alle | 23 |
| VBG | 23 |
| SPSS | 23 |
| RKI | 23 |
| NIR | 22 |
| AMI | 22 |
| Antiseptika | 22 |
| CCTA | 22 |
| DIN | 22 |
| Fast | 22 |
| Faulde | 22 |
| IH | 22 |
| IR | 22 |
| Robert | 22 |
| PPI | 22 |
| Qatar | 22 |
| Science | 22 |
| Student | 22 |
| Wilcoxon | 22 |
| Xi | 22 |
| insbesondere | 22 |
| square | 22 |
| Infections | 21 |
| Age | 21 |
| Impfung | 21 |
| Endoscopic | 21 |
| Clinical | 21 |
| Viren | 21 |
| Africa | 21 |
| ARIMA | 21 |
| AC | 21 |
| OSCE | 21 |
| Markov | 21 |
| innerhalb | 21 |
| PM | 21 |
| Quality | 21 |
| Risikofaktoren | 21 |
| Staphylococcus | 21 |
| Surveillance | 21 |
| TN | 21 |
| sondern | 21 |
| euro | 21 |
| haben | 21 |
| Program | 21 |
| DS | 20 |
| Kap | 20 |
| Iod | 20 |
| Diese | 20 |
| Daten | 20 |
| AP | 20 |
| Contact | 20 |
| Central | 20 |
| CIWA | 20 |
| MRSA | 20 |
| ACLS | 20 |
| Krankenhäusern | 20 |
| PEH | 20 |
| Network | 20 |
| TIPP | 20 |
| soll | 20 |
| eq | 20 |
| Pandemic | 20 |
| TM | 20 |
| beim | 20 |
| T4 | 20 |
| Studie | 20 |
| Rahmen | 20 |
| ROC | 20 |
| CS | 19 |
| Diseases | 19 |
| Development | 19 |
| Clavien | 19 |
| Chronic | 19 |
| Canada | 19 |
| F. | 19 |
| Bitcoin | 19 |
| APACHE | 19 |
| AMS | 19 |
| AHT | 19 |
| IVC | 19 |
| Durch | 19 |
| Resistenzentwicklung | 19 |
| ihre | 19 |
| series | 19 |
| K. | 19 |
| Verwendung | 19 |
| Total | 19 |
| TMRCA | 19 |
| Therapie | 19 |
| Relative | 19 |
| Reduktion | 19 |
| Q | 19 |
| Pearson | 19 |
| KRINKO | 19 |
| France | 18 |
| MAE | 18 |
| Indikation | 18 |
| IBD | 18 |
| Graz | 18 |
| GATCs | 18 |
| IFR | 18 |
| Empfehlung | 18 |
| Eigenschaften | 18 |
| Effect | 18 |
| Daher | 18 |
| Auswahl | 18 |
| MS | 18 |
| MCA | 18 |
| Mutation | 18 |
| Wunden | 18 |
| V | 18 |
| reduziert | 18 |
| nachgewiesen | 18 |
| allen | 18 |
| NS | 18 |
| Vergleich | 18 |
| Texas | 18 |
| Substanzen | 18 |
| Social | 18 |
| PH | 18 |
| PET | 18 |
| Nach | 18 |
| IC | 17 |
| Gruppe | 17 |
| H | 17 |
| HPV | 17 |
| Escherichia | 17 |
| ICD-9 | 17 |
| IOC | 17 |
| Island | 17 |
| Kombination | 17 |
| GA | 17 |
| empfohlen | 17 |
| Economic | 17 |
| Dindo | 17 |
| Desinfektionsmitteln | 17 |
| D. | 17 |
| CEN | 17 |
| Bariatric | 17 |
| Alvim | 17 |
| -1 | 17 |
| LSTM | 17 |
| LR | 17 |
| häufig | 17 |
| Lcn-2 | 17 |
| VP1 | 17 |
| wirksam | 17 |
| van | 17 |
| mehr | 17 |
| ggf | 17 |
| fiat | 17 |
| fi | 17 |
| MA | 17 |
| ab | 17 |
| aufgrund | 17 |
| Teil | 17 |
| PED | 17 |
| Outcomes | 17 |
| OT | 17 |
| Nachweis | 17 |
| NOG | 17 |
| Mikroorganismen | 17 |
| Michael | 17 |
| Kontamination | 16 |
| Hospitalized | 16 |
| Human | 16 |
| IFE | 16 |
| Infektionsprävention | 16 |
| International | 16 |
| Management | 16 |
| Krankenhaushygiene | 16 |
| Life | 16 |
| Liste | 16 |
| Lviv | 16 |
| MM | 16 |
| George | 16 |
| Healthcare | 16 |
| dann | 16 |
| Gastrectomy | 16 |
| GEJ | 16 |
| Evaluation | 16 |
| Die | 16 |
| Denver | 16 |
| Day | 16 |
| Dauer | 16 |
| DC | 16 |
| Carlo | 16 |
| CUSUM | 16 |
| Baseline | 16 |
| 3D | 16 |
| Meta | 16 |
| Mann | 16 |
| sollten | 16 |
| NPV | 16 |
| appendix | 16 |
| PPP | 16 |
| Übertragung | 16 |
| während | 16 |
| α | 16 |
| sollen | 16 |
| meisten | 16 |
| ileus | 16 |
| hohe | 16 |
| einschließlich | 16 |
| diesen | 16 |
| deutlich | 16 |
| benefi | 16 |
| kontaminierten | 16 |
| anderen | 16 |
| Survey | 16 |
| ZIDZ | 16 |
| Regional | 16 |
| Response | 16 |
| Single | 16 |
| STEMI | 16 |
| T2DM | 16 |
| Untersuchungen | 16 |
| Whitney | 16 |
| Wundinfektionen | 16 |
| Preoperative | 16 |
| EBL | 15 |
| HA | 15 |
| EWL | 15 |
| FACS | 15 |
| GB | 15 |
| Grade | 15 |
| IPA | 15 |
| HC | 15 |
| HIDA | 15 |
| Hygiene | 15 |
| IL-6 | 15 |
| INR | 15 |
| ISS | 15 |
| Dkk-3 | 15 |
| Dr. | 15 |
| Act | 15 |
| Death | 15 |
| Database | 15 |
| County | 15 |
| Cochrane | 15 |
| Clinic | 15 |
| Cancer | 15 |
| CFR | 15 |
| Board | 15 |
| Average | 15 |
| Aus | 15 |
| Auch | 15 |
| America | 15 |
| Jahren | 15 |
| AIN | 15 |
| AHA | 15 |
| Inc. | 15 |
| CABG | 15 |
| John | 15 |
| SBP | 15 |
| Kontakt | 15 |
| sowohl | 15 |
| kommen | 15 |
| klinischen | 15 |
| kein | 15 |
| deren | 15 |
| WHO | 15 |
| VT | 15 |
| UC | 15 |
| Subset | 15 |
| Sterilisatoren | 15 |
| Sleeve | 15 |
| STIKO | 15 |
| SEIR | 15 |
| möglich | 15 |
| Robotic | 15 |
| OHCAs | 15 |
| Reunion | 15 |
| LLR | 15 |
| MAP | 15 |
| MCMC | 15 |
| MR | 15 |
| North | 15 |
| Lösung | 15 |
| Objectives | 15 |
| Rates | 15 |
| RR | 15 |
| Rate[Rgn | 15 |
| Reserve | 15 |
| Prävention | 15 |
| Governor | 14 |
| Guidelines | 14 |
| HR | 14 |
| Indocyanine | 14 |
| Information | 14 |
| LPS | 14 |
| Ireland | 14 |
| Leitlinien | 14 |
| MMI | 14 |
| MRCP | 14 |
| GJ | 14 |
| MRE | 14 |
| Gesellschaft | 14 |
| Cholecystectomy | 14 |
| FCH | 14 |
| Einmalgabe | 14 |
| Eingriffe | 14 |
| Desinfektionsverfahren | 14 |
| Daily | 14 |
| Ciprofloxacin | 14 |
| Children | 14 |
| Chicago | 14 |
| Cardiac | 14 |
| Bedingungen | 14 |
| Barrett | 14 |
| Arizona | 14 |
| Al | 14 |
| Mit | 14 |
| Med | 14 |
| RLN | 14 |
| Mittel | 14 |
| VF | 14 |
| λ | 14 |
| β | 14 |
| weil | 14 |
| seine | 14 |
| letzten | 14 |
| en | 14 |
| Nutzen | 14 |
| cm | 14 |
| besteht | 14 |
| antireflux | 14 |
| Zusatz | 14 |
| Working | 14 |
| Vinci | 14 |
| d. | 14 |
| Statistics | 14 |
| RCT | 14 |
| Spearman | 14 |
| PIRA | 14 |
| PTH | 14 |
| Pmus | 14 |
| Polihexanid | 14 |
| Philadelphia | 14 |
| Regel | 14 |
| Republic | 14 |
| SE | 14 |
| Safety | 14 |
| Scale | 14 |
| Hong | 13 |
| Ergebnisse | 13 |
| FGF18 | 13 |
| Finland | 13 |
| Fällen | 13 |
| GEPU | 13 |
| Handschuhe | 13 |
| Medizinprodukte | 13 |
| IP | 13 |
| IfSG | 13 |
| Indikationen | 13 |
| Koch | 13 |
| Krankheitserregern | 13 |
| MAPCM | 13 |
| Entwicklung | 13 |
| Ergebnis | 13 |
| Monte | 13 |
| English | 13 |
| California | 13 |
| ACE | 13 |
| AL | 13 |
| AWMF | 13 |
| Antibiotikums | 13 |
| Blut | 13 |
| CU | 13 |
| Centre | 13 |
| Easter | 13 |
| DP | 13 |
| Dabei | 13 |
| Detection | 13 |
| EGD | 13 |
| ET | 13 |
| East | 13 |
| Methods | 13 |
| Iceland | 13 |
| NASA | 13 |
| 13 | |
| Validierung | 13 |
| Wochen | 13 |
| Ziel | 13 |
| erfolgt | 13 |
| finden | 13 |
| hepatectomy | 13 |
| heute | 13 |
| incisional | 13 |
| konnte | 13 |
| möglichst | 13 |
| pyloroplasty | 13 |
| reinigen | 13 |
| waren | 13 |
| Þ | 13 |
| NIV | 13 |
| U. | 13 |
| hier | 13 |
| Temperaturen | 13 |
| POFU | 13 |
| Singapore | 13 |
| NT | 13 |
| NY | 13 |
| OECD | 13 |
| Oberflächen | 13 |
| PGY1 | 13 |
| ‡ | 13 |
| P1 | 13 |
| POPF | 13 |
| Russia | 13 |
| SAS | 13 |
| SEP | 13 |
| SIRS | 13 |
| Sens | 13 |
| GC | 12 |
| Kampf | 12 |
| HF | 12 |
| Hernia | 12 |
| Händedesinfektionsmittel | 12 |
| IEM | 12 |
| ILE | 12 |
| Improvement | 12 |
| Iraq | 12 |
| Medizinprodukten | 12 |
| Kolonisation | 12 |
| LAGB | 12 |
| LICH | 12 |
| Leitlinie | 12 |
| MAC | 12 |
| MACE | 12 |
| MVC | 12 |
| Menschen | 12 |
| FAP | 12 |
| Flächen | 12 |
| Antibiotikagabe | 12 |
| Einwirkzeit | 12 |
| CRR | 12 |
| -3 | 12 |
| ACASI | 12 |
| Net | 12 |
| Antimicrobial | 12 |
| Bayesian | 12 |
| Belgium | 12 |
| CE | 12 |
| CIT | 12 |
| Centers | 12 |
| Efficacy | 12 |
| Chirurgie | 12 |
| Crohn | 12 |
| Diamond | 12 |
| Dietary | 12 |
| Division | 12 |
| Doppler | 12 |
| Ebola | 12 |
| Effekt | 12 |
| NYC | 12 |
| MII | 12 |
| OGR | 12 |
| USC | 12 |
| Unterschied | 12 |
| Vienna | 12 |
| Virus | 12 |
| Wahl | 12 |
| Wegen | 12 |
| Wert | 12 |
| bereits | 12 |
| beschrieben | 12 |
| erforderlich | 12 |
| erst | 12 |
| grundsätzlich | 12 |
| i. | 12 |
| kommt | 12 |
| medizinischen | 12 |
| paraesophageal | 12 |
| radiochemotherapy | 12 |
| sec | 12 |
| u. | 12 |
| Office | 12 |
| Unit | 12 |
| empfehlen | 12 |
| UGI | 12 |
| Schaben | 12 |
| Times | 12 |
| Orlando | 12 |
| PCA | 12 |
| Personal | 12 |
| QOL | 12 |
| Richtlinie | 12 |
| Robinson | 12 |
| S130-S359 | 12 |
| Operationen | 12 |
| Sec | 12 |
| Sweden | 12 |
| TEP | 12 |
| T3 | 12 |
| TIA | 12 |
| Square | 12 |
| Smith | 12 |
| Senhance | 12 |
| IMA | 11 |
| Konservierung | 11 |
| IMF | 11 |
| IRR | 11 |
| Imaging | 11 |
| Impfungen | 11 |
| Institut | 11 |
| Instrumente | 11 |
| Kaplan | 11 |
| Kong | 11 |
| LV | 11 |
| LEC | 11 |
| LNM | 11 |
| LS | 11 |
| Heller | 11 |
| Laparoscopy | 11 |
| Liver | 11 |
| MERS | 11 |
| Meier | 11 |
| Morgagni | 11 |
| N. | 11 |
| I. | 11 |
| ABEM | 11 |
| Heart | 11 |
| Great | 11 |
| Notest | 11 |
| AHF | 11 |
| AKI | 11 |
| AR | 11 |
| Auftreten | 11 |
| Bekämpfung | 11 |
| Bratzler | 11 |
| Brazil | 11 |
| Commission | 11 |
| Einfluss | 11 |
| Eingriff | 11 |
| England | 11 |
| FEV1 | 11 |
| FRS | 11 |
| FUSE | 11 |
| File | 11 |
| GH | 11 |
| GIS | 11 |
| Geräte | 11 |
| NBHR | 11 |
| Bayes | 11 |
| Objective | 11 |
| keinen | 11 |
| Wells | 11 |
| berücksichtigen | 11 |
| besonders | 11 |
| daher | 11 |
| ersten | 11 |
| esophagectomy | 11 |
| https://doi.org/10.1101/2020.07.21.20158303 | 11 |
| i(t | 11 |
| kappa | 11 |
| liegt | 11 |
| Vor | 11 |
| mindestens | 11 |
| pH1N1/2009v | 11 |
| übertragen | 11 |
| scan | 11 |
| selten | 11 |
| submucosal | 11 |
| zumindest | 11 |
| ® | 11 |
| PAV+ | 11 |
| WBC | 11 |
| neben | 11 |
| Treatment | 11 |
| S1 | 11 |
| PID | 11 |
| Task | 11 |
| PVP | 11 |
| Patients | 11 |
| Paul | 11 |
| RGA | 11 |
| RT | 11 |
| Reduction | 11 |
| Resistenz | 11 |
| Pediatric | 11 |
| SC | 11 |
| San | 11 |
| Sanjuá | 11 |
| Si | 11 |
| Systems | 11 |
| Skills | 11 |
| Spread | 11 |
| Stunden | 11 |
| SN | 11 |
| Syndrome | 11 |
| Hartmann | 10 |
| Iran | 10 |
| Intervention | 10 |
| IPV | 10 |
| High | 10 |
| Hersteller | 10 |
| H&E | 10 |
| HTX | 10 |
| HRQL | 10 |
| Gupta | 10 |
| Gini | 10 |
| Komplikationen | 10 |
| Gesundheitswesen | 10 |
| Kommission | 10 |
| Louisiana | 10 |
| Konzentration | 10 |
| LADG | 10 |
| LAG | 10 |
| Lap | 10 |
| Larven | 10 |
| Lee | 10 |
| Level | 10 |
| Linz | 10 |
| London | 10 |
| MBSAQIP | 10 |
| ME | 10 |
| MEDS | 10 |
| Massachusetts | 10 |
| Framework | 10 |
| German | 10 |
| Base | 10 |
| Frakturen | 10 |
| Form | 10 |
| AA | 10 |
| ABS | 10 |
| Acute | 10 |
| Applikation | 10 |
| Assisted | 10 |
| Atlanta | 10 |
| BO | 10 |
| BS | 10 |
| Michigan | 10 |
| Beispiel | 10 |
| Boston | 10 |
| Box | 10 |
| CPAP | 10 |
| CTP | 10 |
| CXR | 10 |
| Ca | 10 |
| CoV | 10 |
| Covid-19 | 10 |
| Cronbach | 10 |
| Cumulative | 10 |
| DD | 10 |
| Depression | 10 |
| Dokumentation | 10 |
| Education | 10 |
| Erregern | 10 |
| FT | 10 |
| FXIII | 10 |
| Faktoren | 10 |
| Fall | 10 |
| Max | 10 |
| LINX | 10 |
| Ministry | 10 |
| Wirkspektrum | 10 |
| Zealand | 10 |
| abhängig | 10 |
| allerdings | 10 |
| area | 10 |
| b. | 10 |
| bekannt | 10 |
| choledocholithiasis | 10 |
| derzeit | 10 |
| durchzuführen | 10 |
| findet | 10 |
| führen | 10 |
| gute | 10 |
| handelt | 10 |
| hohen | 10 |
| indiziert | 10 |
| jeweils | 10 |
| n= | 10 |
| ob | 10 |
| parechovirus | 10 |
| t. | 10 |
| trocar | 10 |
| usw | 10 |
| weniger | 10 |
| ±δλ | 10 |
| × | 10 |
| ε | 10 |
| ∆k | 10 |
| −1 | 10 |
| Möglichkeit | 10 |
| ZVK | 10 |
| humanmedizinischen | 10 |
| Wasser | 10 |
| SP | 10 |
| Nationwide | 10 |
| War | 10 |
| Neben | 10 |
| Netherlands | 10 |
| P | 10 |
| PCT | 10 |
| PEG | 10 |
| PPV | 10 |
| Person | 10 |
| Personen | 10 |
| Pre | 10 |
| Princess | 10 |
| Python | 10 |
| Richards | 10 |
| PSN | 10 |
| TRPB | 10 |
| TPC | 10 |
| SVCMC | 10 |
| Wang | 10 |
| Units | 10 |
| Thomas | 10 |
| TPLC | 10 |
| Sub | 10 |
| Sprague | 10 |
| Severity | 10 |
| Scientific | 10 |
| Schwangerschaft | 10 |
| Schutz | 10 |
| Vorgehen | 10 |
| LAM | 9 |
| Kinder | 9 |
| Konzentrationen | 9 |
| HAPU | 9 |
| LDP | 9 |
| Jan | 9 |
| Learning | 9 |
| K-12 | 9 |
| IMV | 9 |
| Jahr | 9 |
| Intraoperative | 9 |
| Interventions | 9 |
| Inaktivierung | 9 |
| Illinois | 9 |
| Hospitals | 9 |
| MEDLINE | 9 |
| MDT | 9 |
| PGY | 9 |
| MV | 9 |
| Operative | 9 |
| Gesell | 9 |
| Perioperative | 9 |
| PHQ | 9 |
| PD | 9 |
| PCI | 9 |
| PCC | 9 |
| Nature | 9 |
| MboI | 9 |
| NYCLIX | 9 |
| NGT | 9 |
| Mississippi | 9 |
| Midwest | 9 |
| Metaanalyse | 9 |
| Mesh | 9 |
| 9 | |
| Austrian | 9 |
| Gegenstände | 9 |
| GSD | 9 |
| Campylobacter | 9 |
| CRT | 9 |
| CR | 9 |
| CPB | 9 |
| COV-2 | 9 |
| CMOS | 9 |
| CKD | 9 |
| CIN | 9 |
| CD | 9 |
| Bereichen | 9 |
| Basis | 9 |
| Arrest | 9 |
| Antibiotic | 9 |
| Agency | 9 |
| ADP | 9 |
| Capacity | 9 |
| Cases | 9 |
| Christopher | 9 |
| Dynamics | 9 |
| Florida | 9 |
| Epidemic | 9 |
| Einführung | 9 |
| Effektivität | 9 |
| ESB | 9 |
| EGDT | 9 |
| Durchführung | 9 |
| Convolutional | 9 |
| DpnI | 9 |
| Denmark | 9 |
| Dawley | 9 |
| Dam | 9 |
| DO | 9 |
| DB | 9 |
| PM2.5 | 9 |
| PHQ-2 | 9 |
| Peritonitis | 9 |
| jedem | 9 |
| immer | 9 |
| ihrer | 9 |
| i.v | 9 |
| höheren | 9 |
| h. | 9 |
| führt | 9 |
| erhalten | 9 |
| ergibt | 9 |
| eingesetzt | 9 |
| diverticular | 9 |
| dichlorvos | 9 |
| darf | 9 |
| chemischer | 9 |
| chemischen | 9 |
| bleiben | 9 |
| intraoperatively | 9 |
| laparoscopic | 9 |
| besser | 9 |
| lg | 9 |
| Phase | 9 |
| zwei | 9 |
| worden | 9 |
| weiteren | 9 |
| stellen | 9 |
| sofern | 9 |
| sodass | 9 |
| signifikant | 9 |
| resistente | 9 |
| postoperativer | 9 |
| pCT | 9 |
| nd | 9 |
| ml | 9 |
| mL | 9 |
| liegen | 9 |
| bisher | 9 |
| ned | 9 |
| andere | 9 |
| TAP | 9 |
| Support | 9 |
| Standardization | 9 |
| Sample | 9 |
| STI | 9 |
| SNP | 9 |
| SHP | 9 |
| SAGES | 9 |
| SAEM | 9 |
| Roux | 9 |
| Registry | 9 |
| Redford | 9 |
| RV | 9 |
| ROSC | 9 |
| Zusammenhang | 9 |
| Prehospital | 9 |
| Survival | 9 |
| Riley | 9 |
| TOETVA | 9 |
| VS | 9 |
| Wirkstoff | 9 |
| TTV | 9 |
| West | 9 |
| Wallis | 9 |
| Voraussetzung | 9 |
| Verfügung | 9 |
| W | 9 |
| Urban | 9 |
| Tested[Rgn | 9 |
| Transanal | 9 |
| Taylor | 9 |
| Wäsche | 9 |
| Toupet | 9 |
| Univariate | 9 |
| Hinweise | 8 |
| Hopkins | 8 |
| Huang | 8 |
| Hughes | 8 |
| IL | 8 |
| Hygienemaßnahmen | 8 |
| IL-10 | 8 |
| ILI | 8 |
| HWI | 8 |
| IOPN | 8 |
| Hand | 8 |
| GBP | 8 |
| Güter | 8 |
| Grundsätzlich | 8 |
| Granulozytopenie | 8 |
| Glasgow | 8 |
| Gefahr | 8 |
| Gastric | 8 |
| GBC | 8 |
| Force | 8 |
| Food | 8 |
| Flächendesinfektion | 8 |
| Jahre | 8 |
| Flu | 8 |
| Inter | 8 |
| Medicaid | 8 |
| Krankheiten | 8 |
| Krankheitserreger | 8 |
| Figs | 8 |
| Non | 8 |
| Neutral | 8 |
| Neugeborenen | 8 |
| NVS | 8 |
| NSQIP | 8 |
| nan | 8 |
| Metaanalysen | 8 |
| Mensch | 8 |
| Mean | 8 |
| MSC | 8 |
| MPI | 8 |
| MIA | 8 |
| MH | 8 |
| MAPE | 8 |
| Luft | 8 |
| Los | 8 |
| Lancet | 8 |
| Laboratory | 8 |
| LECS | 8 |
| LDG | 8 |
| LAICGA | 8 |
| Kruskal | 8 |
| Finance | 8 |
| Bewertung | 8 |
| FDG | 8 |
| CPT | 8 |
| CONSTANTS(Constant | 8 |
| CHF | 8 |
| CEA | 8 |
| CAPSI | 8 |
| Bypass | 8 |
| Bodmer | 8 |
| OE | 8 |
| Benjamin | 8 |
| Belastung | 8 |
| Based | 8 |
| BT | 8 |
| BPD | 8 |
| Autoren | 8 |
| Arbeitskreis | 8 |
| Anzahl | 8 |
| Anwender | 8 |
| Angeles | 8 |
| Ampicillin | 8 |
| Alkohole | 8 |
| Administration | 8 |
| Activities | 8 |
| AUD | 8 |
| ATS | 8 |
| CPI | 8 |
| Chemotherapie | 8 |
| FA | 8 |
| Chlorhexidine | 8 |
| Erkrankungen | 8 |
| Epidemiology | 8 |
| Elektra | 8 |
| Einrichtungen | 8 |
| Egypt | 8 |
| Effectiveness | 8 |
| EVS | 8 |
| EVAR | 8 |
| EPI | 8 |
| EHR | 8 |
| Durkheim | 8 |
| Dread | 8 |
| Dor | 8 |
| Deutsche | 8 |
| Deaths | 8 |
| David | 8 |
| Daniel | 8 |
| DFP | 8 |
| Constant | 8 |
| Colorado | 8 |
| Cohort | 8 |
| Cohen | 8 |
| Clip | 8 |
| O | 8 |
| Incubation | 8 |
| OU | 8 |
| hoch | 8 |
| gleichzeitig | 8 |
| foley | 8 |
| erreicht | 8 |
| erfolgen | 8 |
| effektiv | 8 |
| doc_id | 8 |
| davon | 8 |
| danach | 8 |
| cTnI | 8 |
| cTn | 8 |
| bpm | 8 |
| bezüglich | 8 |
| bestätigt | 8 |
| beachten | 8 |
| ausgeschlossen | 8 |
| anhand | 8 |
| Zu | 8 |
| White | 8 |
| Walker | 8 |
| Wales | 8 |
| WR | 8 |
| Vorteil | 8 |
| Vermeidung | 8 |
| hemi | 8 |
| https://doi.org/10.1101 | 8 |
| Vancomycin | 8 |
| insgesamt | 8 |
| Obesity | 8 |
| zeigen | 8 |
| www.nature.com/scientificdata | 8 |
| wirksame | 8 |
| viruziden | 8 |
| sogar | 8 |
| rd | 8 |
| rasch | 8 |
| r2 | 8 |
| qRT | 8 |
| pneumoperitoneum | 8 |
| p\.0001 | 8 |
| p=0.001 | 8 |
| p.01 | 8 |
| organische | 8 |
| offenen | 8 |
| octenidine | 8 |
| nancial | 8 |
| n=12 | 8 |
| miR-124 | 8 |
| konnten | 8 |
| k. | 8 |
| jeweiligen | 8 |
| Verbindungen | 8 |
| kleinen | 8 |
| VPs | 8 |
| SS | 8 |
| SBDP150 | 8 |
| Risikos | 8 |
| Repair | 8 |
| Reinigungs | 8 |
| Region | 8 |
| Rapid | 8 |
| Rank | 8 |
| Qualität | 8 |
| QAV | 8 |
| Protection | 8 |
| Produkten | 8 |
| Price | 8 |
| Portugal | 8 |
| Poland | 8 |
| Period | 8 |
| Patientenzimmer | 8 |
| PVI | 8 |
| POD | 8 |
| PIP | 8 |
| PESI | 8 |
| PA | 8 |
| VP | 8 |
| P=0.001 | 8 |
| SEIRD | 8 |
| Praxishygiene | 8 |
| ST | 8 |
| Tokyo | 8 |
| VI | 8 |
| VEGF | 8 |
| Saharan | 8 |
| VDF | 8 |
| Utah | 8 |
| Unter | 8 |
| Union | 8 |
| Umwelt | 8 |
| Type | 8 |
| Tri | 8 |
| Trade | 8 |
| Uncertainty | 8 |
| Team | 8 |
| Stary | 8 |
| Service | 8 |
| Signal | 8 |
| Spender | 8 |
| Short | 8 |
| Stage | 8 |
| Stewardship | 8 |
| Supplementary | 8 |
| Systematic | 8 |
| TaTME | 8 |
| Histologic | 7 |
| Histological | 7 |
| Hospital[Rgn | 7 |
| Hubei | 7 |
| Hübner | 7 |
| ICCT | 7 |
| Imiquimod | 7 |
| ICP | 7 |
| ISO | 7 |
| K(t | 7 |
| Isolierung | 7 |
| Instrumentendesinfektion | 7 |
| Intensivpatienten | 7 |
| Guideline | 7 |
| Hautantiseptik | 7 |
| Faktor | 7 |
| Green | 7 |
| Gesundheitsfürsorge | 7 |
| Gegensatz | 7 |
| Gastrointestinal | 7 |
| GVL | 7 |
| Fundamentals | 7 |
| Fontan | 7 |
| FlexDex | 7 |
| Financial | 7 |
| Fassung | 7 |
| Factors | 7 |
| FS | 7 |
| FP | 7 |
| LF | 7 |
| FJ | 7 |
| Kingdom | 7 |
| Nations | 7 |
| LVI | 7 |
| Li | 7 |
| FDA | 7 |
| P,0.0001 | 7 |
| OTC | 7 |
| OG | 7 |
| OEC | 7 |
| Nipah | 7 |
| Neumann | 7 |
| NSE | 7 |
| NSCLC | 7 |
| NO2 | 7 |
| NCD | 7 |
| NBI | 7 |
| N95 | 7 |
| Myotomy | 7 |
| Mitarbeiter | 7 |
| Mini | 7 |
| Milben | 7 |
| Metronidazol | 7 |
| Methode | 7 |
| Meckel | 7 |
| Market | 7 |
| MTT | 7 |
| MPO | 7 |
| MPH | 7 |
| MPDS | 7 |
| MIQR | 7 |
| M2 | 7 |
| Long | 7 |
| Linda | 7 |
| FI | 7 |
| Air | 7 |
| Estimation | 7 |
| CC0 | 7 |
| Bezug | 7 |
| Beschäftigten | 7 |
| Beginn | 7 |
| Bakteriurie | 7 |
| Bakteriensporen | 7 |
| Baker | 7 |
| BH | 7 |
| Ausbreitung | 7 |
| Auflage | 7 |
| Aufgrund | 7 |
| Arthropoden | 7 |
| Arbeiten | 7 |
| Approach | 7 |
| Antibiotikatherapie | 7 |
| Anlage | 7 |
| Amoxicillin | 7 |
| Ambulatory | 7 |
| Aim | 7 |
| Accreditation | 7 |
| Academy | 7 |
| Academic | 7 |
| Abstract | 7 |
| Abhängigkeit | 7 |
| Abb | 7 |
| ACD | 7 |
| ABD | 7 |
| 3b | 7 |
| -Prüfverfahren | 7 |
| PHQ-9 | 7 |
| Blanchard | 7 |
| CD31 | 7 |
| Esophagectomy | 7 |
| CH | 7 |
| Eqs | 7 |
| Endo | 7 |
| Einhaltung | 7 |
| EVD | 7 |
| EUR | 7 |
| ETGBD | 7 |
| ES | 7 |
| ERq | 7 |
| ER | 7 |
| EMBASE | 7 |
| EKG | 7 |
| EJ | 7 |
| EDPS | 7 |
| Dosierung | 7 |
| Deutschen | 7 |
| Deshalb | 7 |
| Delhi | 7 |
| De | 7 |
| D&F | 7 |
| Czech | 7 |
| Cuevas | 7 |
| Contacts | 7 |
| Clindamycin | 7 |
| Chile | 7 |
| Chen | 7 |
| Cefazolin | 7 |
| CTx | 7 |
| CSI | 7 |
| CNI | 7 |
| PG | 7 |
| normothermic | 7 |
| PRP | 7 |
| folgende | 7 |
| leicht | 7 |
| lassen | 7 |
| kontaminiert | 7 |
| klinische | 7 |
| jährlich | 7 |
| jejunal | 7 |
| jeder | 7 |
| https | 7 |
| hoher | 7 |
| hinaus | 7 |
| groundtruth | 7 |
| gastrojejunostomy | 7 |
| g. | 7 |
| folgenden | 7 |
| fit | 7 |
| bestimmten | 7 |
| europäischen | 7 |
| est | 7 |
| entweder | 7 |
| entsprechend | 7 |
| ebenfalls | 7 |
| dt | 7 |
| direkt | 7 |
| diesem | 7 |
| defi | 7 |
| darauf | 7 |
| dar | 7 |
| damit | 7 |
| dafür | 7 |
| chemische | 7 |
| lässt | 7 |
| mtDNAs | 7 |
| neurochirurgischen | 7 |
| ≤ | 7 |
| PS | 7 |
| ρ | 7 |
| Überprüfung | 7 |
| zusätzliche | 7 |
| zusätzlich | 7 |
| zeigte | 7 |
| wobei | 7 |
| weitere | 7 |
| verursacht | 7 |
| time | 7 |
| sympathectomy | 7 |
| suture | 7 |
| steht | 7 |
| später | 7 |
| speziellen | 7 |
| sog | 7 |
| sinnvoll | 7 |
| sicher | 7 |
| selbst | 7 |
| seit | 7 |
| schon | 7 |
| sauberen | 7 |
| sauber | 7 |
| potenziell | 7 |
| physikalischen | 7 |
| pCR | 7 |
| p=0.04 | 7 |
| p= | 7 |
| notwendig | 7 |
| bevorzugen | 7 |
| seiner | 7 |
| begrenzt | 7 |
| Series | 7 |
| Sensitivity | 7 |
| Senkung | 7 |
| ScvO | 7 |
| Scott | 7 |
| SPC | 7 |
| SOFA | 7 |
| SICH | 7 |
| SBO | 7 |
| S3 | 7 |
| Rolle | 7 |
| Richtlinien | 7 |
| Richard | 7 |
| Rev | 7 |
| Resistenzen | 7 |
| Reed | 7 |
| Reaktionen | 7 |
| RSG | 7 |
| RPLS | 7 |
| Qb | 7 |
| Präparate | 7 |
| Project | 7 |
| Potential | 7 |
| Peters | 7 |
| Personals | 7 |
| Performance | 7 |
| Pereira | 7 |
| Palliative | 7 |
| PVP- | 7 |
| ausreichend | 7 |
| Sepsis | 7 |
| RHHR | 7 |
| Services | 7 |
| Ultrasound | 7 |
| anterior | 7 |
| Shunt | 7 |
| angesehen | 7 |
| anderer | 7 |
| Zum | 7 |
| Zero | 7 |
| Wände | 7 |
| Wirkstoffe | 7 |
| Wasserdampf | 7 |
| WCMC | 7 |
| Vocera | 7 |
| Viral | 7 |
| Vektoren | 7 |
| VEM | 7 |
| Während | 7 |
| Ukraine | 7 |
| TBC-3214Na | 7 |
| Sofern | 7 |
| Situationen | 7 |
| Term | 7 |
| Sterilisationsverfahren | 7 |
| Steven | 7 |
| TASE | 7 |
| Sudan | 7 |
| TLX | 7 |
| TOF | 7 |
| TPI | 7 |
| Technical | 7 |
| Temperatur | 7 |
| HBOC | 6 |
| Hepatobiliary | 6 |
| Guðbjartsson | 6 |
| HCT | 6 |
| HEP | 6 |
| HLAPD | 6 |
| Gillespie | 6 |
| HLEC | 6 |
| Hautflora | 6 |
| Hepatitis | 6 |
| Händen | 6 |
| Hospitalized[Rgn | 6 |
| Hrsg | 6 |
| Humanmedizin | 6 |
| Händehygiene | 6 |
| IPAA | 6 |
| ISHLT | 6 |
| Ia | 6 |
| GenBank | 6 |
| Infection[Rgn | 6 |
| Indian | 6 |
| Georgia | 6 |
| Failure | 6 |
| Gefährdung | 6 |
| Gebrauch | 6 |
| FGF2 | 6 |
| Injury | 6 |
| FL | 6 |
| FSRS | 6 |
| Fa | 6 |
| Fachgesellschaften | 6 |
| Factor | 6 |
| Faculty | 6 |
| Federal | 6 |
| Fidelity | 6 |
| First | 6 |
| Formulierungen | 6 |
| Frac | 6 |
| Frage | 6 |
| GEMC | 6 |
| GIST | 6 |
| GMS | 6 |
| GYN | 6 |
| Gebiet | 6 |
| Infektionsrisiko | 6 |
| Methoden | 6 |
| Innsbruck | 6 |
| MRC | 6 |
| Materials | 6 |
| Mathematical | 6 |
| Matthew | 6 |
| Means | 6 |
| Medicare | 6 |
| Method | 6 |
| Min | 6 |
| Mykobakterien | 6 |
| NE | 6 |
| NFL | 6 |
| NHL | 6 |
| NIS | 6 |
| NOTECHS | 6 |
| NaOCl | 6 |
| Nebraska | 6 |
| Neoclose | 6 |
| Newcastle | 6 |
| Number | 6 |
| FED | 6 |
| Maryland | 6 |
| MAPK | 6 |
| Insektizide | 6 |
| MALS | 6 |
| Inzidenz | 6 |
| JPY | 6 |
| Japanese | 6 |
| Johns | 6 |
| KF | 6 |
| Ketamine | 6 |
| Kiefer | 6 |
| Kontraindikationen | 6 |
| Krankenhäuser | 6 |
| Krüger | 6 |
| LAGBP | 6 |
| LAR | 6 |
| LCA | 6 |
| LDI | 6 |
| LN | 6 |
| Laerdal | 6 |
| Laser | 6 |
| Levofloxacin | 6 |
| Lin | 6 |
| FESS | 6 |
| BP | 6 |
| Expert | 6 |
| Artikel | 6 |
| Ausmaß | 6 |
| Australian | 6 |
| OLR | 6 |
| Basic | 6 |
| Baumann | 6 |
| Betracht | 6 |
| Bettwanzen | 6 |
| BfArM | 6 |
| Billroth | 6 |
| Britain | 6 |
| Brown | 6 |
| CAH | 6 |
| CD34 | 6 |
| CD4 | 6 |
| CDR | 6 |
| CDSS | 6 |
| CIMT | 6 |
| CIs | 6 |
| CMAPA | 6 |
| Assadian | 6 |
| Annual | 6 |
| CPP | 6 |
| Angaben | 6 |
| 2D | 6 |
| 3a | 6 |
| AAA | 6 |
| ACC | 6 |
| ALPPS | 6 |
| APCT | 6 |
| APSC | 6 |
| ARS | 6 |
| AVR | 6 |
| Achalasia | 6 |
| Additional | 6 |
| Aerosol | 6 |
| Affairs | 6 |
| AgSS | 6 |
| Albert | 6 |
| Allergien | 6 |
| Alternative | 6 |
| Amazon | 6 |
| Analyse | 6 |
| CPOE | 6 |
| CRBSI | 6 |
| Excel | 6 |
| Diagnosis | 6 |
| Diebold | 6 |
| Director | 6 |
| Douglas | 6 |
| Drake | 6 |
| Duffy | 6 |
| Dynamic | 6 |
| EMSC | 6 |
| EOB | 6 |
| EPIC | 6 |
| ERK | 6 |
| EVLT | 6 |
| Eastern | 6 |
| Econ | 6 |
| Ecuador | 6 |
| Einwirkung | 6 |
| Electronic | 6 |
| Engineering | 6 |
| Evidenz | 6 |
| Example | 6 |
| Diagnostik | 6 |
| Design | 6 |
| CRPS | 6 |
| Deputy | 6 |
| CSF | 6 |
| CSSCA | 6 |
| CTM-3 | 6 |
| CVS | 6 |
| Calot | 6 |
| Cefuroxim | 6 |
| Characteristics | 6 |
| Clara | 6 |
| Classification | 6 |
| Colorectal | 6 |
| Coma | 6 |
| Communication | 6 |
| Computer | 6 |
| Cretaceous | 6 |
| Cross | 6 |
| CðtÞ | 6 |
| DTI | 6 |
| Databases | 6 |
| Delphi | 6 |
| OB | 6 |
| GWI | 6 |
| Occupational | 6 |
| gut | 6 |
| erhöhter | 6 |
| ermöglichen | 6 |
| erreichen | 6 |
| fingerstick | 6 |
| fl | 6 |
| gastroparesis | 6 |
| gluconate | 6 |
| group | 6 |
| großen | 6 |
| high | 6 |
| Wenn | 6 |
| hingegen | 6 |
| hygienischen | 6 |
| ii | 6 |
| ij | 6 |
| int | 6 |
| je | 6 |
| mesoappendix | 6 |
| mid | 6 |
| mikrobiozid | 6 |
| erhöhte | 6 |
| einfachen | 6 |
| dürfen | 6 |
| durchgeführt | 6 |
| Wien | 6 |
| Wiesbaden | 6 |
| XhoI | 6 |
| Young | 6 |
| Zeit | 6 |
| achalasia | 6 |
| antimikrobiellen | 6 |
| ausreichende | 6 |
| bakteriziden | 6 |
| behandelt | 6 |
| besitzen | 6 |
| bezeichnet | 6 |
| cefazolin | 6 |
| chirurgischen | 6 |
| chlorhexidine | 6 |
| crura | 6 |
| dN | 6 |
| data | 6 |
| definiert | 6 |
| mmHg | 6 |
| nSILC | 6 |
| nachweisbar | 6 |
| vena | 6 |
| verhindern | 6 |
| verschiedenen | 6 |
| viruzid | 6 |
| vollständig | 6 |
| weisen | 6 |
| wenig | 6 |
| wichtigsten | 6 |
| wirken | 6 |
| zeigt | 6 |
| zuletzt | 6 |
| zwar | 6 |
| | | 6 |
| Ö | 6 |
| Überwachung | 6 |
| überlegen | 6 |
| ν | 6 |
| σ | 6 |
| Oncology | 6 |
| ∼ | 6 |
| verbessert | 6 |
| unterlegen | 6 |
| needlescopic | 6 |
| uVATS | 6 |
| oberen | 6 |
| orale | 6 |
| oralen | 6 |
| p=0.002 | 6 |
| p=0.008 | 6 |
| primär | 6 |
| reduzieren | 6 |
| routinemäßig | 6 |
| rugal | 6 |
| sPESI | 6 |
| schlechter | 6 |
| schweren | 6 |
| seroma | 6 |
| sichere | 6 |
| sicheren | 6 |
| signifikanten | 6 |
| stehen | 6 |
| trotz | 6 |
| ts | 6 |
| Werte | 6 |
| truncal | 6 |
| Weight | 6 |
| Rifampicin | 6 |
| Pseudomonas | 6 |
| Purpose | 6 |
| QUAT | 6 |
| RIH | 6 |
| Rasch | 6 |
| Reinigungstuch | 6 |
| Replication | 6 |
| Resolution | 6 |
| Respiratory | 6 |
| Risiken | 6 |
| STD | 6 |
| Roberts | 6 |
| Réunion | 6 |
| S2 | 6 |
| SCHIP | 6 |
| SEK | 6 |
| SIDG | 6 |
| SL | 6 |
| SNS | 6 |
| SQ | 6 |
| Protocol | 6 |
| Prospective | 6 |
| Prolene | 6 |
| Press | 6 |
| Onkologie | 6 |
| Organ | 6 |
| Weibchen | 6 |
| Outbreak | 6 |
| Oxford | 6 |
| P=0.038 | 6 |
| PAA | 6 |
| PAN | 6 |
| PHP | 6 |
| PMN | 6 |
| POST | 6 |
| PRE | 6 |
| PVT | 6 |
| Party | 6 |
| Pests | 6 |
| Peter | 6 |
| Pflege | 6 |
| Pneumonie | 6 |
| Polymerase | 6 |
| STATA | 6 |
| Pakistan | 6 |
| Sarayacu | 6 |
| TRO | 6 |
| Targeting | 6 |
| Technology | 6 |
| Thailand | 6 |
| Turkey | 6 |
| UICC | 6 |
| USD | 6 |
| USGPIV | 6 |
| Unterschiede | 6 |
| VAH | 6 |
| VUR | 6 |
| Verbände | 6 |
| Versajet | 6 |
| Versorgung | 6 |
| Vicryl | 6 |
| Vielzahl | 6 |
| Wallhäußers | 6 |
| Schlussdesinfektion | 6 |
| Wagenlehner | 6 |
| Von | 6 |
| Taiwan | 6 |
| Van | 6 |
| TNF | 6 |
| Sulbactam | 6 |
| Secretariat | 6 |
| Screening | 6 |
| Section | 6 |
| TI | 6 |
| Schutzimpfungen | 6 |
| Sporen | 6 |
| Staphylokokken | 6 |
| Stellenwert | 6 |
| Structured | 6 |
| Subset[Rgn | 6 |
| Statistical | 6 |
| Sunday | 6 |
| TEM | 6 |
| Swiss | 6 |
| TGF | 6 |
| TBT | 6 |
| TC | 6 |
| TE | 6 |
| Immunisierung | 5 |
| Islands | 5 |
| Imperial | 5 |
| Intuitive | 5 |
| Intraoperatively | 5 |
| Institutions | 5 |
| Intima | 5 |
| Instrumenten | 5 |
| Infektionskrankheiten | 5 |
| Institutional | 5 |
| Infektionsprophylaxe | 5 |
| James | 5 |
| Income | 5 |
| Ja | 5 |
| Kindern | 5 |
| Janice | 5 |
| Kriterien | 5 |
| LIC | 5 |
| LHD | 5 |
| LGD | 5 |
| Icelandic | 5 |
| LG | 5 |
| LDLT | 5 |
| Kontrollen | 5 |
| Jason | 5 |
| Kondili | 5 |
| Knowledge | 5 |
| KNS | 5 |
| Journal | 5 |
| Johnson | 5 |
| Jeffrey | 5 |
| Immune | 5 |
| Helicobacteraceae | 5 |
| Ibrahim | 5 |
| HRV | 5 |
| Hazard | 5 |
| Hawk | 5 |
| Hall | 5 |
| Habedank | 5 |
| HUVEC | 5 |
| HT | 5 |
| HPD | 5 |
| Hemodynamic | 5 |
| HIE | 5 |
| HI | 5 |
| HEMS | 5 |
| LLND | 5 |
| HBOT | 5 |
| HCC | 5 |
| Helicobacter | 5 |
| Herabsetzung | 5 |
| ISAO | 5 |
| Häufigkeit | 5 |
| IRI | 5 |
| IRAP | 5 |
| IPMN | 5 |
| INTEG | 5 |
| IL-1 | 5 |
| IJ | 5 |
| Houston | 5 |
| Hess | 5 |
| House | 5 |
| Histopathological | 5 |
| Hinweis | 5 |
| Hierbei | 5 |
| Hiatal | 5 |
| Hg | 5 |
| LIH | 5 |
| Myasthenia | 5 |
| LSAGB | 5 |
| NCB | 5 |
| NOK | 5 |
| NJ | 5 |
| NIH | 5 |
| NEDS | 5 |
| NEC | 5 |
| NCS | 5 |
| NADH | 5 |
| Microsoft | 5 |
| NACRT | 5 |
| MutH | 5 |
| Mortality | 5 |
| Morawska | 5 |
| Moran | 5 |
| Models | 5 |
| NUI | 5 |
| Naber | 5 |
| Natural | 5 |
| Nd | 5 |
| Neutropenie | 5 |
| Nn | 5 |
| Northern | 5 |
| Nutrition | 5 |
| OCD | 5 |
| OCP | 5 |
| ODG | 5 |
| OLS | 5 |
| OMIP | 5 |
| OMOs | 5 |
| OOHCA | 5 |
| Gründen | 5 |
| Obwohl | 5 |
| Mitteilung | 5 |
| Meyer | 5 |
| LUQ | 5 |
| Library | 5 |
| Loss | 5 |
| Log | 5 |
| Ljungan | 5 |
| Livadiotis | 5 |
| Liu | 5 |
| Lichtenstein | 5 |
| Lewis | 5 |
| Menge | 5 |
| Lebensmittel | 5 |
| Lagerung | 5 |
| La | 5 |
| LWCA | 5 |
| LWBS | 5 |
| LVAD | 5 |
| Lyoplant | 5 |
| MAS | 5 |
| MDMA | 5 |
| MGB | 5 |
| MMTBI | 5 |
| MNCH | 5 |
| MSF | 5 |
| Magnamosis | 5 |
| Maier | 5 |
| Maschinen | 5 |
| Mass | 5 |
| Material | 5 |
| Materialien | 5 |
| May. | 5 |
| Maßnahme | 5 |
| Mechanisms | 5 |
| MedWAR | 5 |
| Guangdong | 5 |
| CBV | 5 |
| Gruppen | 5 |
| Bonferroni | 5 |
| CCL | 5 |
| CBF | 5 |
| CASY | 5 |
| Burgess | 5 |
| Buffalo | 5 |
| Braden | 5 |
| Biliary | 5 |
| Bangladesh | 5 |
| Bildung | 5 |
| Betalaktamantibiotika | 5 |
| Bestimmung | 5 |
| Berücksichtigung | 5 |
| Berlin | 5 |
| Begriff | 5 |
| CDH | 5 |
| CHG | 5 |
| CM | 5 |
| CNN | 5 |
| CO2 | 5 |
| COVID‐19 | 5 |
| CPR+ITD | 5 |
| CRM | 5 |
| CTAS | 5 |
| Chain | 5 |
| Challenge | 5 |
| Chikungunya | 5 |
| Chinese | 5 |
| Chlor | 5 |
| Chroma | 5 |
| Clavulansäure | 5 |
| Cml | 5 |
| Bard | 5 |
| Bakteriämien | 5 |
| Comparative | 5 |
| AIDS | 5 |
| Advanced | 5 |
| Abtötung | 5 |
| Abdomen | 5 |
| AV | 5 |
| ARF | 5 |
| AIT | 5 |
| AIC | 5 |
| Bacteriophage | 5 |
| AGIHO | 5 |
| ABG | 5 |
| A3963 | 5 |
| = | 5 |
| -Teil | 5 |
| Orleans | 5 |
| Agreement | 5 |
| Airborne | 5 |
| Alaniz | 5 |
| Alexander | 5 |
| Allison | 5 |
| Alter | 5 |
| Alvarado | 5 |
| Americans | 5 |
| Antibiotikum | 5 |
| Antiparasitika | 5 |
| Apple | 5 |
| Art | 5 |
| Asia | 5 |
| BAL | 5 |
| BBQ | 5 |
| BI | 5 |
| BTS | 5 |
| Commerce | 5 |
| Comprehensive | 5 |
| Grundlagen | 5 |
| FRCSC | 5 |
| Flächendesinfektionsmitteln | 5 |
| Flächendesinfektionsmittel | 5 |
| Fluorchinolone | 5 |
| Flora | 5 |
| Fischer | 5 |
| Fieber | 5 |
| FIT | 5 |
| Entscheidung | 5 |
| FBS | 5 |
| Executive | 5 |
| Exchange | 5 |
| Evolution | 5 |
| Evans | 5 |
| Ethicon | 5 |
| Freisetzung | 5 |
| Friday | 5 |
| FðaÞ | 5 |
| GD | 5 |
| GIA | 5 |
| GNB | 5 |
| GP | 5 |
| Gas | 5 |
| Gastmeier | 5 |
| Gastroenterology | 5 |
| Gazette | 5 |
| Genome | 5 |
| Gesundheitseinrichtungen | 5 |
| Gewebe | 5 |
| Grant | 5 |
| Grund | 5 |
| Grundlage | 5 |
| Erregerspektrum | 5 |
| Enterobacteriaceae | 5 |
| Consortium | 5 |
| DMH | 5 |
| Dieses | 5 |
| Decision | 5 |
| Dec | 5 |
| Darüber | 5 |
| Dampf | 5 |
| DTT | 5 |
| DM | 5 |
| Endokarditis | 5 |
| DG | 5 |
| D2 | 5 |
| Cox | 5 |
| Council | 5 |
| Corporation | 5 |
| Consumer | 5 |
| Diet | 5 |
| Directorate | 5 |
| Disinfection | 5 |
| Drug | 5 |
| EBWL | 5 |
| EG | 5 |
| EMT | 5 |
| ESB2 | 5 |
| ESB3 | 5 |
| ESI | 5 |
| Early | 5 |
| Ebenso | 5 |
| Effective | 5 |
| Einwirkungszeit | 5 |
| Emerg | 5 |
| Emerging | 5 |
| EndoFLIP | 5 |
| Oral | 5 |
| SFT | 5 |
| Ottawa | 5 |
| dagegen | 5 |
| diverticulectomy | 5 |
| diskutiert | 5 |
| dihydrochloride | 5 |
| dienen | 5 |
| df | 5 |
| deshalb | 5 |
| daVinci | 5 |
| board | 5 |
| dL | 5 |
| corticosteroid | 5 |
| contra | 5 |
| cholangiogram | 5 |
| chirurgisches | 5 |
| cardia | 5 |
| dokumentieren | 5 |
| droperidol | 5 |
| einige | 5 |
| einigen | 5 |
| einmalige | 5 |
| endoscopic | 5 |
| enthalten | 5 |
| entwickeln | 5 |
| esophagogastroduodenoscopy | 5 |
| fanden | 5 |
| gastroplasty | 5 |
| gebildet | 5 |
| gelagert | 5 |
| gelegentlich | 5 |
| gemacht | 5 |
| general | 5 |
| gering | 5 |
| c. | 5 |
| biopsy | 5 |
| gezeigt | 5 |
| X | 5 |
| Zellen | 5 |
| Zeitpunkt | 5 |
| Zahl | 5 |
| Younes | 5 |
| Yale | 5 |
| YAG | 5 |
| Wundinfektion | 5 |
| berücksichtigt | 5 |
| Wunde | 5 |
| Wundantiseptik | 5 |
| Wischdesinfektion | 5 |
| Wilson | 5 |
| Whipple | 5 |
| Werden | 5 |
| Zhang | 5 |
| Zukunft | 5 |
| Zusammenarbeit | 5 |
| alkoholische | 5 |
| aller | 5 |
| anesthesia | 5 |
| angegeben | 5 |
| arthroplasty | 5 |
| aseptischen | 5 |
| aufbereitet | 5 |
| auftreten | 5 |
| außer | 5 |
| bakteriellen | 5 |
| behördlich | 5 |
| beinhaltet | 5 |
| belzebuth | 5 |
| beobachtet | 5 |
| gewährleistet | 5 |
| gleichen | 5 |
| Wallhäusers | 5 |
| signi | 5 |
| vielen | 5 |
| viele | 5 |
| viel | 5 |
| teilweise | 5 |
| sterilen | 5 |
| stellt | 5 |
| serosa | 5 |